Bingel A (1949)

Wirkt das Diphtherieheilserum bei der menschlichen Diphtheriekrankheit spezifisch durch seinen Antitoxingehalt oder unspezifisch [Does curative diphtheria serum act specifically through its anti-toxin content or non-specifically in human diphtheria]? Deutsche Medizische Wochenschrift 74:101-103.

Key passage(s)


“In 1918 I published a very extensive communication (Bingel 1918) reporting my observations on nearly 1000 diphtheria patients, of whom one half had been treated with serum containing anti-toxin and the other with ordinary (so called simple) serum. I had proceeded in the following way: exactly in the order of admission [to the hospital] every first case received anti-toxin serum and every second case simple serum, without regard to the age of the patient or the severity of the disease. Through this “alternating” method, I believed I would achieve, with a large sample of patients, statistically unchallengeable results (see Martini). I kept the identity of the serum type strictly secret from the assistant physicians and the nurses; nobody other than me knew about it.  I hold this circumstance to be very particularly important; for it is only in this way that an unprejudiced evaluation can be guaranteed.”

Translation by Ulrich Tröhler


Adolf Bingel (1879-1953)

JLL Book of EssaysHave you read the James Lind Library's Introduction to Fair Tests of Treatments?

We have edited, updated and abridged all of the Essays from the Library for 2019, and lavishly illustrated them with examples from the history of fair tests of treatments.  Share and enjoy!

Download the PDF